Medifast Inc (MED)

Price$12.56Cached quote
MEDNYSE
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$385.8M$602.5M$1.07B$1.60B$1.53B$934.8M$713.7M$501.0M$301.6M$274.5M$272.8M$285.3M$324.1M$318.6M$298.2M$257.6M$169.7M
Gross profit$275.2M$444.6M$775.9M$1.14B$1.13B$697.8M$536.9M$379.9M$227.8M$205.7M$201.3M$209.2M$240.6M$235.9M$224.5M$192.5M$124.4M
Gross margin71.33%73.80%72.37%71.34%73.89%74.65%75.22%75.83%75.54%74.91%73.80%73.33%74.24%74.05%75.29%74.73%73.28%
Research & development$4.3M$4.6M$4.6M$4.5M$4.4M$2.8M$2.7M$2.2M$1.5M$2.0M$1.8M$1.3M—————
Operating expenses$289.4M$441.7M$649.4M$955.6M$911.4M$563.7M$445.8M$310.8M$188.2M$178.8M$172.6M$179.0M$202.2M$208.8M$197.1M$160.8M$105.9M
Operating income−$14.2M$2.9M$126.4M$184.8M$216.2M$134.2M$91.0M$69.1M$39.6M$26.9M$28.7M$30.2M$38.4M$27.1M$27.4M$31.6M$18.5M
Operating margin−3.68%0.48%11.79%11.56%14.17%14.35%12.76%13.78%13.14%9.78%10.52%10.60%11.85%8.52%9.18%12.28%10.90%
EBITDA$29,000$15.6M$139.5M$195.8M$223.1M$138.5M$95.7M$73.5M$43.8M$32.3M$35.8M$38.3M$46.3M$35.5M$35.7M$37.5M$23.8M
EBITDA margin0.01%2.59%13.01%12.25%14.62%14.81%13.40%14.67%14.54%11.75%13.12%13.42%14.29%11.15%11.98%14.56%14.00%
Net income−$18.7M$2.1M$99.4M$143.6M$164.0M$102.9M$77.9M$55.8M$27.7M$17.8M$20.1M$13.2M$24.0M$15.9M$18.5M$19.6M$11.4M
Net profit margin−4.84%0.35%9.27%8.98%10.75%11.00%10.92%11.14%9.19%6.50%7.35%4.62%7.40%4.98%6.22%7.61%6.69%
Basic EPSper basic share-$1.70$0.19$9.13$12.82$14.01$8.74$6.62$4.67$2.32$1.51$1.68$1.04$1.74$1.16$1.33$1.39$0.84
Diluted EPSper diluted share-$1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03$1.73$1.16$1.31$1.35$0.77

Owners

Reported shareholders

Reference date Jun 30, 2026
RENAISSANCE TECHNOLOGIES LLC · 6.96% of listed sharesSteamboat Capital Partners, LLC · 6.32% of listed sharesChard Daniel R · ≈4.69% of listed sharesTWO SIGMA INVESTMENTS, LP · 4.31% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 3.99% of listed sharesCHARLES SCHWAB INVESTMENT MANAGEMENT INC · 3.55% of listed sharesBlackRock, Inc. · 3.30% of listed sharesDIMENSIONAL FUND ADVISORS LP · 3.25% of listed sharesAMERICAN CENTURY COMPANIES INC · 2.85% of listed sharesMORGAN STANLEY · 2.62% of listed sharesGOLDMAN SACHS GROUP INC · 2.17% of listed sharesMARSHALL WACE, LLP · 2.16% of listed sharesAQR CAPITAL MANAGEMENT LLC · 2.11% of listed sharesPeapod Lane Capital LLC · 1.99% of listed sharesLido Advisors, LLC · 1.97% of listed sharesTrexquant Investment LP · 1.90% of listed sharesJANE STREET GROUP, LLC · 1.47% of listed sharesCOMMONS CAPITAL, LLC · 1.34% of listed sharesQuinn Opportunity Partners LLC · 1.14% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 1.08% of listed shares
6.96%of listed shares
RENAISSANCE TECHNOLOGIES LLC778.61K shares · Jun 30, 2026
View holders
Top 20 reported holders of MED
Holder% owned
RENAISSANCE TECHNOLOGIES LLC
6.96%778.61K shares
Steamboat Capital Partners, LLC
6.32%706.7K shares
Chard Daniel R
≈4.69%524.78K shares
TWO SIGMA INVESTMENTS, LP
4.31%481.38K shares
VANGUARD CAPITAL MANAGEMENT LLC
3.99%446.61K shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
3.55%397K shares
BlackRock, Inc.
3.30%369.5K shares
DIMENSIONAL FUND ADVISORS LP
3.25%363.39K shares
AMERICAN CENTURY COMPANIES INC
2.85%318.91K shares
MORGAN STANLEY
2.62%292.51K shares
GOLDMAN SACHS GROUP INC
2.17%243.09K shares
MARSHALL WACE, LLP
2.16%241.65K shares
AQR CAPITAL MANAGEMENT LLC
2.11%236.43K shares
Peapod Lane Capital LLC
1.99%222.58K shares
Lido Advisors, LLC
1.97%220.34K shares
Trexquant Investment LP
1.90%212.68K shares
JANE STREET GROUP, LLC
1.47%164.88K shares
COMMONS CAPITAL, LLC
1.34%149.92K shares
Quinn Opportunity Partners LLC
1.14%127.11K shares
GEODE CAPITAL MANAGEMENT, LLC
1.08%121.07K shares

Percentages use 11.18M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys4$246.7K disclosed value
Sells (SEC code S)0$0.00 disclosed value
4 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 11, 2026Form 4SCHLACKMAN SCOTTDirectorBuyCommon Stock2.5K$12.53$31.3K30.5K
May 8, 2026Form 4SCHLACKMAN SCOTTDirectorBuyCommon Stock2.5K$12.65$31.6K28.0K
Mar 20, 2026Form 4Chard Daniel RChairman & CEOBuyCommon Stock · indirect17.7K$10.11$178.7K17.7K
Jun 13, 2025Form 4Chard Daniel RChairman & CEOBuyCommon Stock · indirect381$13.13$5.0K149.7K

Community posts

It’s quiet here.

No posts about MED yet. Start the conversation.

Write the first post